|

Autologous Tumor Infiltrating Lymphocytes Clinical Trials

2 actively recruiting trials

Also known as: GC101 TIL injection

Pipeline

Phase 1: 2

Top Sponsors

  • Zhiyong Huang1
  • Shanghai Juncell Therapeutics1

Indications

  • Cancer2
  • Liver Disease1
  • Non-small Cell Lung Cancer Metastatic1
  • Liver Cancer1
  • Lung Cancer1

Other2 trials

A Phase Ib Study of GC101 in NSCLC
Phase 1
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Advanced Liver Cancer
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.